Quoin Pharmaceuticals Ltd.
QNRX Nasdaq
SEC CIK 1671502
Follow Quoin Pharmaceuticals Ltd.
Weekly email: filings, results, news
Net income
−$5.4M
−45.3% vs same quarter last year
EPS, diluted
-
Operating cash flow
−$3.1M
+14.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$15.8M |
| FY24 | - | −$9M |
| FY23 | - | −$8.7M |
| FY22 | - | −$9.4M |
| FY21 | $0 | −$21.5M |
| FY20 | $0 | −$2.1M |
| FY19 | $0 | −$1.6M |
| FY18 | - | - |
News
No stories filed under Quoin Pharmaceuticals Ltd. yet - coverage appears here as the news feed clusters it.